Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 593

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 593
---
 | ​ | ​    | ​ |  73,666 | ​ | ​ |
| Net cash (used in) provided by financing activities                   | ​ | ​ | ​                              | ​ |  -1,989 | ​ | ​ | ​ | ​    | ​ |   1,676 | ​ | ​ |
| Net (decrease) increase in cash, cash equivalents and restricted cash | ​ | ​ | ​                              | $ | -15,122 | ​ | ​ | ​ | ​    | $ |     634 | ​ | ​ |

Net cash used in operating activities Net cash used in operating activities for the nine months ended September 30, 2024 consisted primarily of a net loss of $63.2 million and a $13.3 million cash outflow from net changes in operating assets and liabilities, partially offset by a $19.6 million cash inflow from net non-cash charges. The change in operating assets and liabilities primarily consisted of a decrease of $19.1 million in accounts payable and accrued expenses primarily due to operating payments made during the period and a $4.3 million cash lease payment

339

TABLE OF CONTENTS

made to assign Cara’s corporate lease to a third party on November 1, 2024, partially offset by a decrease in prepaid expenses of $5.8 million, primarily related to a decrease in prepaid clinical costs, a decrease in accounts receivable, net — related party of $2.3 million, and an increase of $2.1 million for lease incentives reimbursed to Cara during the 2024 period. Net non-cash charges primarily consisted of stock-based compensation expense of $6.6 million, non-cash interest expense related to the Original HCR Agreement of $5.9 million, an impairment of Cara’s right-of-use asset of $4.3 million, and an inventory write-down of $2.5 million. Net cash used in operating activities for the nine months ended September 30, 2023 consisted primarily of a net loss of $86.2 million, partially offset by a $11.4 million cash inflow from net non-cash charges and a $0.1 million cash inflow from net changes in operating assets and liabilities. Net non-cash charges primarily consisted of stock-based compensation expense of $10.1 million, and the noncash lease expense of $1.2 million relating to Cara’s Stamford operating leases. The change in operating assets and liabilities primarily consisted of cash infl